1. Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit

   • Ersilia M. DeFilippis
   • Michael M. Givertz

   Invited Commentary 17 May 2016 Pages: 111 - 118

   

2. Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling

   • Wynn G. Hunter
   • Jacob P. Kelly
   • Svati H. Shah

   Biomarkers of Heart Failure (W H W Tang, Section Editor) 23 May 2016 Pages: 119 - 131

   

3. Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?

   • Ruth F. Dubin
   • Sanjiv J. Shah

   Pharmacologic Therapy (W H W Tang, Section Editor) 27 April 2016 Pages: 132 - 139

   

4. Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient

   • Christopher W. Jensen
   • Andrew B. Goldstone
   • Y. Joseph Woo

   Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (A Hasan, Section Editor) 30 May 2016 Pages: 140 - 150